Christine Ocampo | Chief Accounting Officer |
Keith Katkin | CEO |
Cornelia Haag-Molkenteller | Chief Medical Officer |
Michael McFadden | Chief Commercial Officer |
Ritu Baral | Cowen |
Edward Marks | JPMorgan |
Hello, and welcome to the Urovant Sciences Third Quarter 2018 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference is being recorded. And I now like to introduce your host for today's call, Christine Ocampo.